Gáspár, Zsófia
Szabó, Bálint Gergely
Ábrahám, Anita
Várnai, Zsuzsanna
Kiss-Dala, Noémi
Szlávik, János
Sinkó, János
Vályi-Nagy, István
Lakatos, Botond
Funding for this research was provided by:
Semmelweis University
Article History
Received: 20 November 2022
Accepted: 28 February 2023
First Online: 9 March 2023
Declarations
:
: The study was in accordance with the Helsinki Declaration and national ethical standards. The institutional review board of South Pest Central Hospital, National Institute of Haematology and Infectious Diseases approved the study protocol. The National Institute of Pharmacy and Nutrition approved the off-label use of remdesivir detailed in the manuscript (ExternalRef removed).
: Written informed consent was obtained from each patient.
: The authors affirm that human research participants provided informed consent for publication of the data in Table InternalRef removed.
: The authors declare no competing interests.